A Repeat Dose Positron Emission Tomography Study With GSK1144814
Status:
Completed
Trial end date:
2009-10-25
Target enrollment:
Participant gender:
Summary
This study described in the present protocol consists of two parts. Part A is a multiple
ascending dose study to evaluate the safety, tolerability and pharmacokinetics of ascending
doses of GSK1144814. Part B is an open label design in healthy male subjects to assess the
GSK1144814 Neurokinin1 receptor occupancy.